SCHEMBL3479616

SCHEMBL3479616

CN1CCN(c2cccc(Cl)c2)c2ccc(-c3ncccn3)cc2C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 2/20 0.44
KCNH2 Q12809 4/20 0.44
DRD2 P14416 3/20 0.44
DRD3 P35462 3/20 0.44
HRH4 Q9H3N8 1/20 0.43
LMNA P02545 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
GAA P10253 2/20 0.39
DRD4 P21917 1/20 0.38
HTR2A P28223 1/20 0.38
MAPKAPK2 P49137 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
TSHR P16473 1/20 0.38
HTT P42858 1/20 0.38
BCL2A1 Q16548 1/20 0.38
TP53 P04637 1/20 0.38
ADORA3 P0DMS8 1/20 0.37
ADORA1 P30542 1/20 0.37
AVPR2 P30518 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3479700 0.88 SCN9A (0.46) SCN9AKCNH2HRH4LMNASMN1; SMN2
SCHEMBL3231467 0.88 SCN9A (0.48) SCN9AKCNH2DRD2DRD3HRH4
SCHEMBL3230914 0.87 SCN9A (0.45) SCN9AHRH4MAPKAPK2DHFR
SCHEMBL3233371 0.86 SCN9A (0.44) SCN9ADRD2DRD3HRH4HTR2A
SCHEMBL3227222 0.86 SCN9A (0.46) SCN9AKCNH2DRD2DRD3HRH4
SCHEMBL3479963 0.86 HRH4 (0.44) SCN9AKCNH2DRD2DRD3HRH4
SCHEMBL3479576 0.84 SCN9A (0.44) SCN9AKCNH2ALDH1A1SCN5A
SCHEMBL3226298 0.84 SCN9A (0.45) SCN9AKCNH2DRD2DRD3LMNA
SCHEMBL3231301 0.84 CYP11B1 (0.50) SCN9AKCNH2DRD2DRD3LMNA
SCHEMBL3479437 0.83 SCN9A (0.43) SCN9AKCNH2DRD2DRD3HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096546-B2 Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin ALBANY MOLECULAR RESEARCH, INC. (US) 2015-08-04 US disclosed
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ALBANY MOLECULAR RESEARCH, INC. (US) 2010-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ADRA1B, ADRB1, ADRA1D SCN9A 795/4885KCNH2 537/4885DRD2 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.